MARKET

GOSS

GOSS

Gossamer Bio
NASDAQ
0.1677
+0.0031
+1.88%
Pre Market: 0.1719 +0.0042 +2.50% 07:01 07/02 EDT
OPEN
0.1670
PREV CLOSE
0.1646
HIGH
0.1697
LOW
0.1626
VOLUME
41.15K
TURNOVER
0
52 WEEK HIGH
3.870
52 WEEK LOW
0.1400
MARKET CAP
81.98M
P/E (TTM)
-0.2142
1D
5D
1M
3M
1Y
5Y
1D
Gossamer Bio Sets Conversion Terms for Convertible Notes
TipRanks · 21h ago
Gossamer Bio announces determination of conversion rate for senior secured notes
TipRanks · 21h ago
Gossamer Bio sets initial warrant exercise price at $0.34 per share
PUBT · 22h ago
GOSSAMER BIO, INC. ANNOUNCES DETERMINATION OF CONVERSION RATE FOR 7.50% CONVERTIBLE SENIOR SECURED FIRST LIEN NOTES DUE 2030 AND EXERCISE PRICE FOR PURCHASE WARRANTS
Reuters · 22h ago
Weekly Report: what happened at GOSS last week (0622-0626)?
Weekly Report · 3d ago
Gossamer Bio Price Target Cut to $2.00/Share From $5.00 by HC Wainwright & Co.
Dow Jones · 6d ago
Gossamer Bio Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6d ago
Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright
TipRanks · 6d ago
More
About GOSS
Gossamer Bio, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) including pulmonary arterial hypertension (PAH) and PH associated with interstitial lung disease (PH-ILD). The Company's lead product candidate is Seralutinib (GB002), is an investigational inhaled, small-molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor, being evaluated in a Phase III clinical trial for the treatment of PAH. Inhaled seralutinib, which is designed to act on both isoforms of the PDGFR. Seralutinib is designed to inhibit multiple kinases in the pathology of PAH. The PDGFR is a tyrosine kinase receptor which, when activated by its agonist, induces cellular proliferation. The c-KIT pathway was also identified as a factor involved in pulmonary vascular remodeling, particularly in the cells implicated in perivascular inflammation.

Webull offers Gossamer Bio Inc stock information, including NASDAQ: GOSS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOSS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOSS stock methods without spending real money on the virtual paper trading platform.